Ronald C Renaud JR Insider Trading $KERX KERYX BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for Ronald C Renaud JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald C Renaud JR. Ronald C Renaud JR is Chief Financial Officer in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in CHIMERIX INC ($CMRX) and Director in PTC THERAPEUTICS, INC. ($PTCT) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and in Atara Biotherapeutics, Inc. ($ATRA) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Chief Executive Officer in Translate Bio, Inc. ($TBIO) and Chief Executive Officer, Pres. in Translate Bio, Inc. ($TBIO) and See Remarks in Translate Bio, Inc. ($TBIO).
Ronald C Renaud JR in KERYX BIOPHARMACEUTICALS INC
Trading Symbol: KERXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald C Renaud JR: Chief Financial Officer
Holdings: 94,027 shares
Current Value: $503,044
Latest Transaction: Feb 16 2007
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ronald C Renaud JR in KERYX BIOPHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, ATRA, CMRX, KERX, PTCT, TBIO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 16 2007 | KERX | KERYX BIOPHARMACEU ... | Renaud Ronald C JR | Chief Financial Off ... | Payment of Exercise | F | 11.79 | 5,973 | 70,422 | 94,027 | 100 K to 94 K (-5.97 %) |
Page: 1